Aortyx is a pioneer company that aims to provide efficient treatments for vascular diseases through the development of endovascular devices. The devices focus on tissue regeneration by mimicking the aorta biomechanical environment and provide a suitable milieu for cell migration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta. The company's mission is to deliver the best available treatments to patients with the most advanced technology, and they are a spin-off from the IQS School of Engineering and Hospital Clínic de Barcelona.